Challenges Facing Radiation Oncologists in The Management of Older Cancer Patients: Consensus of The International Geriatric Radiotherapy Group

Abstract

The management of older cancer patients remains difficult because of data paucity. Radiation oncologists need to identify potential issues which could affect treatment of those patients. A workshop was organized in Barcelona among international radiation oncologists with special interest in the management of older cancer patients on April 22, 2018. The following consensus was reached: 1. Older cancer patients often faced unconscious discriminating bias from cancer specialists and institutions because of their chronological age. 2. Advances in radiotherapy techniques have allowed patients with multiple co-morbidities precluding surgery or systemic therapy to achieve potential cure in early disease stages. 3. The lack of biomarkers for frailty remains an impediment to future research. 4. Access to healthcare insurance and daily transportation remains an issue in many countries; 5. Hypofractionation, brachytherapy, or stereotactic techniques may be ideally suited for older cancer patients to minimize transportation issues and to improve tolerance to radiotherapy. 6. Patients with locally advanced disease who are mentally and physically fit should receive combined therapy for potential cure. 7. The role of systemic therapy alone or combined with radiotherapy for frail patients needs to be defined in future clinical trials because of targeted agents or immunotherapy may be less toxic compared to conventional chemotherapy.

Axillary Lymph Node Involvement in Breast Cancer: A Random Walk Model of Tumor Burden

“…The selection was limited to mastectomy without radiotherapy to avoid treatment interaction. Age was limited to >50 and <65 years to reduce the influence of age-related co-morbidity and to reduce the variability with age in the receipt of treatments [6-7]. After cleaning the data of discrepancies, e.g.…”

Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group

“…Thus, the combination of immunotherapy and radiotherapy may be an attractive concept to improve survival and quality of life for older cancer patients during this uncertain time. As an international organization devoted to the care of older cancer patients, women, and minority, the International Geriatric Radiotherapy Group ( http://www.igrg.org ) [ 13 ] would like to take the initiative to recommend an innovative treatment to that population who is often discriminated. This review examines the preliminary data reporting the possible beneficial effect of immunotherapy and radiotherapy and proposes a new paradigm for the management of older cancer patients during the COVID-19 era.…”

Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

“…Generally, due to a decline of physical and physiological functions, many older patients cannot tolerate ICI combination immunotherapy, chemotherapy, radiotherapy, or targeted therapy. Some reports have also demonstrated that ICI combination immunotherapy, chemotherapy, radiotherapy, and/or targeted therapy is less effective in older people than in younger people (5,(24)(25)(26)(27).…”